ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1,2,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2,5,Vascular resistance systemic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
5,1,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,Y
6,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
7,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
8,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
8,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8,3,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
9,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
9,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
9,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
10,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
10,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
11,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
11,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
12,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
13,1,Therapeutic response increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
14,1,Therapeutic response increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
15,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
15,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
15,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
15,5,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
15,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
15,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
15,8,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
15,9,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
15,10,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
16,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
17,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
17,2,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
17,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
17,4,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
17,5,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
17,6,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
18,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
18,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
18,3,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
19,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
20,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
20,2,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
20,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
20,4,Tachyphylaxis,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,1,Confusion postoperative,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
21,2,Mental status changes postoperative,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
21,3,Metabolic alkalosis,Metabolic alkaloses,Acid-base disorders,Metab,N
21,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
23,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
23,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
24,1,Catheter site extravasation,Implant and catheter site reactions,Administration site reactions,Genrl,N
24,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
25,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
25,2,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
26,2,Blood pressure immeasurable,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
26,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
26,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
27,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,1,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
29,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
29,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
30,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
31,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
34,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
35,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
35,2,Procedural hypotension,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
35,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
36,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
36,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
37,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
37,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
38,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
38,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
38,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
38,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
38,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
39,1,Administration site extravasation,Administration site reactions NEC,Administration site reactions,Genrl,N
39,2,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
39,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
39,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
39,5,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
39,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
40,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
40,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
41,2,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
42,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
42,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
